|
National Stock Number(NSN): 6505-01-388-2483 (6505013882483, 013882483)
| NIIN: |
01-388-2483 |
Item Name: |
PRAVASTATIN SODIUM TABLETS |
INC: |
48378
|
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
48378 |
| ISC: |
5 |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Sep-01-1995 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-411-7120 |
Item Name: |
PRAVASTATIN SODIUM TABLETS |
| FSC: |
6505 |
Replacement Date: |
Sep-01-1995 |
|
INC: |
48378 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
L94-032 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00003-0194-50 |
0NWX1
|
BRISTOL-MYERS SQUIBB PHARMACEUTICAL GROUP SQUIBB US PHARMACEUTICAL DIV |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
PRAVACHOL |
0NWX1
|
BRISTOL-MYERS SQUIBB PHARMACEUTICAL GROUP SQUIBB US PHARMACEUTICAL DIV |
H |
5 |
1 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
|
M |
|
1 |
|
$192.29 |
BT |
|
C2201X- |
|
H |
| DF |
S9M |
H |
|
M |
|
1 |
|
$192.29 |
BT |
|
------- |
|
H |
| DN |
S9M |
H |
|
M |
|
1 |
|
$192.29 |
BT |
|
9L----- |
|
H |
| DS |
S9M |
H |
|
M |
|
1 |
|
$192.29 |
BT |
|
------- |
|
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
100 TT |
|
|
|
|
| DF |
K |
100 TT |
|
|
|
|
| DN |
K |
100 TT |
|
|
|
|
| DS |
K |
100 TT |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| TEXT |
GENERAL CHARACTERISTICS ITEM DESCRIPTION |
CONTAINS 40 MG PRAVASTATIN SODIUM ACTIVE INGREDIENT;100 TABLETS PER BT |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
|
3 |
H |
|
|
|
|
| FSKX |
|
|
3 |
H |
|
|
|
|
| N9LM |
|
|
3 |
H |
|
|
|
|
|